Targacept Announces Decision by AstraZeneca to Advance AZD1446 in Alzheimer’s Disease

Friday, January 6th, 2012

Targacept, Inc. , a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that AstraZeneca has informed the company that it plan

Read the original:
Targacept Announces Decision by AstraZeneca to Advance AZD1446 in Alzheimer’s Disease

Tags: ... continue reading

Posted in Alzheimer's Disease | No Comments »